The latest news & events

Keep up to date with company updates, industry news, investor
press releases and event information.

Investor News - General : 13 Dec 2021

New Study Describes How Kneat is Supporting Merck Sharp & Dohme’s Digital Transformation

LIMERICK, Ireland, December 13, 2021 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or the “Company”)  a leader in digitizing and automating validation and quality processes, is pleased to announce a global e-Validation study that details its partnership with life sciences leader Merck Sharp & Dohme

Read More
Investor News - General : 9 Dec 2021

Deloitte Names Kneat Ireland’s Third Fastest Growing Technology Company

LIMERICK, Ireland, December 9, 2021 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or the “Company”)  a leader in digitizing and automating validation and quality processes, is pleased to announce it has been ranked 3rd in the prestigious 2021 Deloitte Ireland Technology Fast 50 list.

Read More
Investor News - General : 15 Nov 2021

Kneat Announces Graduation to the Toronto Stock Exchange

LIMERICK, Ireland, November 15, 2021 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat” or the “Company”)  a leader in digitizing and automating validation processes, is pleased to announce that, as of market open today, its common shares will begin trading on the Toronto Stock Exchange (TSX) under the

Read More
Investor News - General : 9 Nov 2021

Kneat Achieves Record Revenues in Q3 2021 Driven by Customer Expansion

LIMERICK, Ireland, November 9, 2021 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat” or “the Company”) a leader in digitizing and automating validation processes, today announced strong financial results for the three and nine-month periods ended  September 30 th , 2021.  All dollar amounts are

Read More
Investor News - General : 4 Nov 2021

Kneat Announces Release Date for Third Quarter Financial Results

LIMERICK, Ireland, November 4, 2021 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat” or the “Company”) a leader in digitizing and automating validation processes, announced today that the Company will release its financial results for the quarter ended September 30, 2021, after TSX market close on

Read More
Investor News - General : 25 Oct 2021

Kneat Announces Conditional Approval to List on the Toronto Stock Exchange

LIMERICK, Ireland, October 25, 2021 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat” or the “Company”)  a leader in digitizing and automating validation processes, is pleased to announce that it has received conditional approval to uplist (the “Uplisting”) its common shares (the “Common Shares”) to the

Read More
Events : 24 Sep 2021

Kneat to Exhibit at KenX CSV & Software Assurance University 2021

KenX CSV & Software Assurance University 2021 The KenX CSV & Software Assurance University takes place in San Diego from…

Read More
Events : 17 Sep 2021

Kneat to Attend PharmaTalk 2022

PharmaTalk 2022 PharmaTalk 2022 takes place in Berlin from the 28th-29th June.  PharmaTalk 2022 is a leading annual meeting that…

Read More
Events : 17 Sep 2021

Kneat to Feature at The 2021 RQA International QA Conference

2021 RQA International QA Conference The 2021 RQA International QA Conference takes place virtually from November 3rd-5th. This event will…

Read More
Events : 17 Sep 2021

Kneat to Attend ManuPharma Connect 2021

ManuPharma Connect 2021 ManuPharma Connect 2021 will be delivered virtually from November 2nd-3rd.  ManuPharma Connect enables you to have the…

Read More
Events : 17 Sep 2021

Kneat to Exhibit at The 2021 ISPE Annual Meeting & Expo USA

2021 ISPE Annual Meeting & Expo USA The 2021 ISPE Annual Meeting & Expo USA takes place in Boston on…

Read More
Events : 17 Sep 2021

Kneat Set to Take Part at IVT Validation Week USA

IVT Validation Week USA The 2021 IVT Validation Week USA takes place in Philadelphia from October 19th-28th. IVT Validation Week…

Read More

Sign Up to Our Newsletter

Contact

Talk to us

Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.

Europe: +353-61-203826
USA: +1 888 88 KNEAT
Canada: +1 902 706 9074